Return to Article Details
PHARMACOKINETIC AND PHARMACODYNAMIC OPTIMIZATION OF H. PYLORI ERADICATION THERAPY IN PATIENTS WITH ANTIBIOTIC-RESISTANT H. PYLORI INFECTION